Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicity.
作者信息
Yelnik Cécile M, Xie Xianhong, Guerra Marta M, Costedoat-Chalumeau Nathalie, Khosroshahi Arezou, Kamen Diane L, Schwartz Noa, Katz Patricia, Minett Margaret, Amoss R Toby, Fu April, Guettrot-Imbert Gaëlle, Lazaro Estibaliz, Le Guern Véronique, Oates Jim, Dall'Era Maria, Yazdany Jinoos, Molto Anna, Kim Mimi Y, Salmon Jane E
机构信息
Département de Médecine Interne et d'Immunologie Clinique, Universite de Lille, Lille, France.
Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, New York, USA.
出版信息
Ann Rheum Dis. 2024 Feb 15;83(3):404-406. doi: 10.1136/ard-2023-224952.
Abstract
摘要
相似文献
1
Prevalence of clinically meaningful antiphospholipid antibodies in patients with systemic lupus erythematosus varies by race and ethnicity.系统性红斑狼疮患者中具有临床意义的抗磷脂抗体的患病率因种族和民族而异。
Ann Rheum Dis. 2024 Feb 15;83(3):404-406. doi: 10.1136/ard-2023-224952.
2
Increased risk of acute and chronic microvascular renal lesions associated with antiphospholipid antibodies in patients with systemic lupus erythematosus: A systematic review and meta-analysis.系统性红斑狼疮患者抗磷脂抗体相关的急性和慢性微血管肾损伤风险增加：系统评价和荟萃分析。
Autoimmun Rev. 2022 Oct;21(10):103158. doi: 10.1016/j.autrev.2022.103158. Epub 2022 Jul 28.
3
Antiphospholipid antibodies and the risk of autoimmune hemolytic anemia in patients with systemic lupus erythematosus: A systematic review and meta-analysis.抗磷脂抗体与系统性红斑狼疮患者自身免疫性溶血性贫血的风险：一项系统评价和荟萃分析。
Autoimmun Rev. 2022 Jan;21(1):102913. doi: 10.1016/j.autrev.2021.102913. Epub 2021 Aug 8.
4
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry").抗磷脂抗体阳性患者的血小板减少症和自身免疫性溶血性贫血：抗磷脂综合征临床试验与国际网络联盟（APS ACTION）临床数据库及储存库（“登记处”）的描述性分析
Lupus. 2025 May;34(6):617-625. doi: 10.1177/09612033251332258. Epub 2025 Apr 3.
5
Association of antiphospholipid antibodies with valvulopathy in systemic lupus erythematosus: a systematic review.抗磷脂抗体与系统性红斑狼疮患者心脏瓣膜病的相关性：系统综述。
Clin Rheumatol. 2011 Feb;30(2):165-71. doi: 10.1007/s10067-010-1662-5. Epub 2011 Jan 5.
6
Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis.抗磷脂综合征与复发性流产：系统评价和荟萃分析。
J Reprod Immunol. 2017 Sep;123:78-87. doi: 10.1016/j.jri.2017.09.007. Epub 2017 Sep 20.
7
Cardiac valve involvement in systemic lupus erythematosus and primary antiphospholipid syndrome: lack of correlation with antiphospholipid antibodies.心脏瓣膜受累于系统性红斑狼疮和原发性抗磷脂综合征：与抗磷脂抗体缺乏相关性。
Int J Cardiol. 1995 Sep;51(2):117-26. doi: 10.1016/0167-5273(95)02357-3.
8
Antiphospholipid antibodies and non-thrombotic manifestations of systemic lupus erythematosus.抗磷脂抗体与系统性红斑狼疮的非血栓形成表现
Lupus. 2018 Apr;27(4):665-669. doi: 10.1177/0961203317734924. Epub 2017 Oct 19.
9
Risk of developing antiphospholipid antibodies following viral infection: a systematic review and meta-analysis.病毒感染后抗磷脂抗体产生的风险：一项系统评价和荟萃分析。
Lupus. 2018 Apr;27(4):572-583. doi: 10.1177/0961203317731532. Epub 2017 Sep 24.
10
Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.SLE 患者非标准抗磷脂抗体谱分析：血栓性 SLE 患者的鉴别及血栓复发风险。
Lupus. 2020 Apr;29(5):490-498. doi: 10.1177/0961203320909952. Epub 2020 Mar 4.
引用本文的文献
1
Thrombocytopenia and autoimmune hemolytic anemia in antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid syndrome alliance for clinical trials and InternatiOnal networking (APS ACTION) clinical database and repository ("Registry").抗磷脂抗体阳性患者的血小板减少症和自身免疫性溶血性贫血：抗磷脂综合征临床试验与国际网络联盟（APS ACTION）临床数据库及储存库（“登记处”）的描述性分析
Lupus. 2025 May;34(6):617-625. doi: 10.1177/09612033251332258. Epub 2025 Apr 3.
2
Association Between Novel Antiphospholipid Antibodies and Adverse Pregnancy Outcomes.新型抗磷脂抗体与不良妊娠结局之间的关联
Obstet Gynecol. 2025 Jan 1;145(1):55-64. doi: 10.1097/AOG.0000000000005729. Epub 2024 Sep 19.
3
Systemic Lupus Erythematosus Causing Rapid Progression of Mitral Valve Disease.系统性红斑狼疮导致二尖瓣疾病快速进展。
JACC Case Rep. 2024 Aug 7;29(15):102429. doi: 10.1016/j.jaccas.2024.102429.
本文引用的文献
1
Race, Ethnicity, and Disparities in the Risk of End-Organ Lupus Manifestations Following a Systemic Lupus Erythematosus Diagnosis in a Multiethnic Cohort.种族、民族与系统性红斑狼疮患者发生器官损害风险的关系：一项多民族队列研究
Arthritis Care Res (Hoboken). 2023 Jan;75(1):34-43. doi: 10.1002/acr.24892. Epub 2022 Aug 15.
2
Predictors of Pregnancy Outcomes in Patients With Lupus: A Cohort Study.狼疮患者妊娠结局的预测因素：一项队列研究。
Ann Intern Med. 2015 Aug 4;163(3):153-63. doi: 10.7326/M14-2235.
3
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS).关于明确抗磷脂综合征（APS）分类标准更新的国际共识声明。
J Thromb Haemost. 2006 Feb;4(2):295-306. doi: 10.1111/j.1538-7836.2006.01753.x.
4
Epidemiology of the antiphospholipid antibody syndrome.抗磷脂抗体综合征的流行病学
J Autoimmun. 2000 Sep;15(2):145-51. doi: 10.1006/jaut.2000.0409.
5
Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.抗磷脂抗体：系统性红斑狼疮（SLE）及非SLE疾病中的抗心磷脂抗体和狼疮抗凝物。患病率及临床意义。
Ann Intern Med. 1990 May 1;112(9):682-98. doi: 10.7326/0003-4819-112-9-682.
Zotero 插件